SANTA ROSA, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its management will be presenting at the J.P. Morgan 33rd Annual Healthcare Conference on January 13, 2015 in San Francisco.
TriVascular management is scheduled to present at 1:30pm PT. Interested individuals can access the live audio webcast on the investor relations section of the Company's website at: http://www.trivascular.com. The webcast will be available on the Company's website for two weeks following completion of the presentation.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair (EVAR) system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.
CONTACT: Company Contact: Michael R. Kramer Chief Financial Officer (707) 543-8709 Media Contact: Vivek K. Jayaraman VP, Global Sales & Marketing (707) 543-8804 email@example.com Investor Relations Contact: Westwicke Partners Jamar Ismail (415) 513-1282 Jamar.firstname.lastname@example.orgSource:TriVascular Technologies, Inc.